Table 2.
Hepatotoxicity of EGCG based on animal models.
| Animal type | EGCG dosage (mg/kg/d) | Route of administration | Duration | Results | Reference |
|---|---|---|---|---|---|
| Female Swiss albino mice | 108, 67.8, 21.1, and 6.6 | i.p. and p.o. | 14 d | i.p. treatment increased serum bilirubin markers; p.o. treatment did not show any dose-dependent changes except ALT marker. 14 d tolerable dose of EGCG was 21.1 mg/kg for i.p. and 67.8 mg/kg for p.o. | [67] |
| Male Kunming mice | 55 | i.p. | 5 d | Serum ALT, AST, 4-HNE, IL-2, IL-6, and IL-10 and hepatic γH2AX were raised. Hepatic Nrf2-target gene expression was increased. | [70] |
| 70 | 2 d | The fatality rate was 100%. | |||
| 125 | Single dose | Serum ALT, AST, 4-HNE, IL-6, and IL-10 and hepatic γH2AX were raised. Hepatic nuclear and cytosolic Nrf2 proteins were suppressed. | |||
| Male Kunming mice | 45 | i.p. | 7 d | Mouse growth was not affected. The dosage was considered as maximum tolerable dose. | [71] |
| 55 and 75 | 5 d | Hepatotoxicity occurred. Major hepatic antioxidant enzymes were suppressed. Nrf2-mediated rescue response was induced. | |||
| 75, 100, 200, and 400 | Single dose | Mice died in a dose-dependent manner. | |||
| 200 | 4, 12, and 24 h | The Nrf2 pathway was not activated; Nrf2 and its target genes were suppressed. | |||
| Male ND-4 mice | 750 | i.g. | 5 d | ALT was slightly increased. Histopathology of the liver showed congestion of sinusoids and central and portal veins. | [72] |
| 1500 | Single dose | ALT was markedly increased. Histopathology of the liver showed degenerative hepatocytes and a small number of vacuoles. | |||
| Male CF-1 mice | 500 | i.g. | 7 d | Mouse survival was reduced by 30%. | [65] |
| 750 | 7 d | Mouse survival was reduced by 75%. Hepatic MDA, MT, and γH2AX were increased. | |||
| 1500 | Single dose | ALT was increased by 108-fold. Mouse survival was reduced by 85%. EGCG-2′-cysteine and EGCG-2″-cysteine were detected in the urine. | |||
| Wistar rats of both sexes | 1868 | p.o. | Single dose | Mice were lethargic and their respiration was labored. | [73] |
| Male CD-1 mice | 100, 150, and 300 | i.p. | Single dose | Plasma ALT was increased. Mice died within 24 h. | [68] |
| Mice | 50, 200, and 400 | i.p. | 24 h | EGCG thiol conjugates (EGCG-2′-cysteinyl and EGCG-2″-cysteinyl) were detected in the urine. | [74] |
| Female Swiss-Webster mice | 50 | i.p. | 7 d | 67% of mice died. Plasma ALT activity was elevated. Severe hepatic necrosis occurred. | [75] |